ArticleOncology letters2017

Use of gemcitabine as a second-line treatment following chemotherapy with folfirinox for metastatic pancreatic adenocarcinoma.

Matthieu Sarabi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.